why choose us

First received: December 18, 2023

Clinical Trial: Early-onset Dupilumab Effects in CRSwNP

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Chronic Rhinosinusitis With Nasal Polyps

Study Type: INTERVENTIONAL


Official Title: Early Changes in Type 2 Inflammatory Cytokines, Respiratory Oscillometry, and Sinonasal Microbiome With Dupilumab Treatment for Chronic Rhinosinusitis With Nasal Polyps

Brief Summary: While we know that Dupilumab has profound effects in patients with CRSwNP, these are often seen months later after treatment initiation; however, in practice, patients often endorse feeling significantly better within days of their first injection.No studies have investigated the molecular basis for such an acute change.This study proposes that specific cytokine changes in phenotype in addition to microbiome and oscillometry effects play a synergistic role in producing this effect.

Read more